Koninklijke DSM N.V. Stock Other OTC
Equities
RDSMY
US7802491081
Consumer Goods Conglomerates
Sales 2024 * | 12.63B 13.64B | Sales 2025 * | 13.3B 14.36B | Capitalization | 27.84B 30.05B |
---|---|---|---|---|---|
Net income 2024 * | 452M 488M | Net income 2025 * | 781M 843M | EV / Sales 2024 * | 2.43 x |
Net Debt 2024 * | 2.87B 3.09B | Net Debt 2025 * | 2.61B 2.82B | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
61.6
x | P/E ratio 2025 * |
35.6
x | Employees | - |
Yield 2024 * |
2.4% | Yield 2025 * |
2.36% | Free-Float | 25.03% |
Latest transcript on Koninklijke DSM N.V.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
Director/Board Member | 62 | 23-01-31 |
1st Jan change | Capi. | |
---|---|---|
+14.44% | 890B | |
+0.13% | 239B | |
+24.97% | 179B | |
-2.82% | 132B | |
+40.56% | 85.9B | |
-4.45% | 74.7B | |
-8.86% | 54.74B | |
-25.96% | 38.39B | |
+37.59% | 37.28B |